Ipamorelin

SKU: orb1685436

Description

Ipamorelin (NNC-26-0161) is a selective growth hormone secretagogue peptide used in research to study GH release. It has been shown to stimulate longitudinal bone growth in rat models, making it relevant for investigations into growth, metabolism, and tissue repair.

Key Properties

• CAS Number: 170851-70-4
• MW: 711.85
• Formula: C₃₈H₄₉N₉O₅
• SMILES: C([C@@H](NC([C@H](CC1=CN=CN1)NC(C(C)(C)N)=O)=O)C(N[C@H](CC2=CC=CC=C2)C(N[C@@H](CCCCN)C(N)=O)=O)=O)C3=CC4=C(C=C3)C=CC=C4
• Target: Others

Bioactivity

• In Vivo:
  In pentobarbital anaesthetised rats, ipamorelin released GH with a potency and efficacy comparable to GHRP-6 (ED50 = 80+/-42nmol/kg and Emax = 1545+/-250ng GH/ml vs 115+/-36nmol/kg and 1167+/-120ng GH/ml). In conscious swine, ipamorelin released GH with an ED50 = 2.3+/-0.03 nmol/kg and an Emax = 65+/-0.2 ng GH/ml plasma. Again, this was very similar to GHRP-6 (ED50 = 3.9+/-1.4 nmol/kg and Emax = 74+/-7ng GH/ml plasma).
• In Vitro:
  In vitro, ipamorelin released GH from primary rat pituitary cells with a potency and efficacy similar to GHRP-6 (ECs) = 1.3+/-0.4nmol/l and Emax = 85+/-5% vs 2.2+/-0.3nmol/l and 100%). A pharmacological profiling using GHRP and growth hormone-releasing hormone (GHRH) antagonists clearly demonstrated that ipamorelin, like GHRP-6, stimulates GH release via a GHRP-like receptor

Storage & Handling

• Storage: keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
• Expiration Date: 12 months from date of receipt.
• Disclaimer: For research use only

Alternative Names

Ipamorelin, NNC-26-0161

Compound Identifiers

PubChem CID

9831659